ACER THERAPEUTICS INC (ACER)
US00444P1084 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -26.24M | -15.37M | -22.89M | -29.42M | -21.28M | |||
| Depreciation Amortization | 66.04K | 70.91K | 70.00K | 60.00K | 30.00K | |||
| Change In Working Capital | -7.40M | 13.45M | 3.08M | -2.82M | 3.35M | |||
| Interest Paid | 136.50K | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 3.32M | 1.72M | 2.71M | 2.67M | 1.32M | |||
| OPERATING CASH FLOW | -30.25M | -134.91K | -17.03M | -29.51M | -16.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -171.17K | -54.94K | -10.00K | -180.00K | -100.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -171.17K | -54.94K | -10.00K | -180.00K | -100.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 11.53M | 4.00M | 560.00K | N/A | N/A | |||
| Stock Issued/Repurchased | 8.91M | 3.14M | 10.16M | 90.00K | 42.71M | |||
| Other Financing Activity | -397.90K | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 20.04M | 7.14M | 10.72M | 90.00K | 42.71M | |||
| CHANGE IN CASH | -10.38M | 6.95M | -6.32M | -29.60M | 26.02M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.25M | -134.91K | -17.03M | -29.51M | -16.59M | |||
| Capital Expenditure | -171.17K | -54.94K | -10.00K | -180.00K | -100.00K | |||
| FREE CASH FLOW | -30.42M | -189.85K | -17.04M | -29.69M | -16.69M | |||
All data in USD